Bids Are Invited For Select The Proposal Capable Of Generating The Most Advantageous Result For The Acquisition Of Medicines To Meet The Demand Of The Uepg Hospital Complex.

(L1) 6501.73193-Alteplase, 10 Mg, Lyophilized Powder For Injection Solution, Ampoule Vial, Diluent, 10 Ml, Route Of Administration: Intravenous, Units. Size: Unit, (L2) 6607.69204-Sodium Bicarbonate Pa, Acs, Cas No. 144-55-8, Chemical Formula: Nahco3, Packaging: Bottle With 100G, (L3) 6501.1299-Etilefrine, Hydrochloride, 10 Mg/Ml, Injectable Solution, Ampoule, 1 Ml, Route Of Administration: Subcutaneous/Intramuscular/Intravenous, (L4) 6502.1100-Fentanyl, Citrate + Droperidol, 0.05 Mg + 2.5 Mg/Ml, 2 Ml, Route Of Administration: Intramuscular/Intravenous, Ordinance 344/98 : A1, (L5) 6501.1393-Benzylpenicillin Potassium, 5,000,000 Iu, Powder For Solution For Injection, 01/15/2025, (L6) 6501.966-Sulfamethoxazole + Trimethoprim, 40 Mg + 8 Mg/Ml, Oral Suspension, Bottle, 100 Ml, Cup/Syringe Dosage, % Accepted Variation (Up) In The Primary Packaging Unit Of Measurement: 20, Route Of Administration: Oral, (L7) 6501.1279-Dantrolene Sodium, 20 Mg, 60 Ml, (L8) 6501.8499-Dexmedetomidine, 100 Mcg/ Ml, (L9) 6501.828-Mebendazole, 20 Mg/Ml, 30 Ml, Dosing Cup, (L10) 6501.933-Sodium Picosulfate, 7.5Mg/Ml, Drops Solution, Dripper Bottle, 20Ml